Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-582-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 376, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
PCED1A hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr20:2839270-2839293 HITS-CLIP POSITIVE DIRECT TarBase 7.0
IPO8 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.638
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chr12:30630743-30630766 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CCNB1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr5:69177281-69177293 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FBXO21 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr12:117144459-117144481 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TRAFD1 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.504
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr12:112125649-112125668 HITS-CLIP POSITIVE DIRECT TarBase 7.0
AKIRIN2 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.972
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Haecker Irina et al. 2012 IP Bone Marrow BCBL1 N/A N/A
Location Method Result Regulation Validation Type Source
chr6:87675198-87675215 HITS-CLIP POSITIVE DIRECT TarBase 7.0
USP15 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr12:62391323-62391343 PAR-CLIP POSITIVE DIRECT TarBase 7.0
GLUL hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Skalsky Rebecca L. et al. 2012 IP N/A LCL35 N/A N/A
Location Method Result Regulation Validation Type Source
chr1:182384268-182384288 PAR-CLIP POSITIVE DIRECT TarBase 7.0
TMEM127 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr2:96253836-96253857 HITS-CLIP POSITIVE DIRECT TarBase 7.0
FLNB hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:58081672-58081699 HITS-CLIP POSITIVE DIRECT TarBase 7.0
DDX56 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr7:44571689-44571711 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZFP37 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr9:113042416-113042441 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MYC hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr8:127741260-127741274 PAR-CLIP POSITIVE DIRECT TarBase 7.0
UBAP2 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr9:33944608-33944630 PAR-CLIP POSITIVE DIRECT TarBase 7.0
MTCH1 hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr6:36969672-36969694 HITS-CLIP POSITIVE DIRECT TarBase 7.0
RTF1 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.831
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr15:41471326-41471343 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SLC5A6 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.480
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr2:27199989-27200008 PAR-CLIP POSITIVE DIRECT TarBase 7.0
ITGAV hsa-miR-582-3p low: 0 high: 1 1 1 1 0.717
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr2:186636144-186636160 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GLCE hsa-miR-582-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Whisnant Adam W et al. 2013 IP Cervix TZMBL N/A shRNAs against HIV-1
Location Method Result Regulation Validation Type Source
chr15:69269137-69269148 PAR-CLIP POSITIVE DIRECT TarBase 7.0
RBM26 hsa-miR-582-3p low: 0 high: 1 1 1 1 0.640
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:emetine
Location Method Result Regulation Validation Type Source
chr13:79312647-79312674 HITS-CLIP POSITIVE DIRECT TarBase 7.0